|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.50 CHF | -0.45% |
|
-1.48% | +18.94% |
| 12-12 | Swiss Market Index Ends Week Downbeat; UBS Group Soars | MT |
| 12-12 | Novartis AG Breaks Ground on Flagship Manufacturing Hub in North Carolina | CI |
Chart calendar Novartis AG
Upcoming events on Novartis AG
| 2026-01-11 | J.P. Morgan Healthcare Conference | Add to your calendar Google Apple ICS format |
| 2026-02-03 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
| 2026-03-05 | Annual General Meeting | Add to your calendar Google Apple ICS format |
| 2026-04-27 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-07-20 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-11-02 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2027-02-02 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Novartis AG
| 2025-12-11 | San Antonio Breast Cancer Symposium - Abstract No - # PS3-09-08 |
| 2025-12-11 | San Antonio Breast Cancer Symposium - Abstract No - # PS3-09-15 |
| 2025-12-11 | San Antonio Breast Cancer Symposium - Abstract No - # PS3-08-27 |
| 2025-12-11 | San Antonio Breast Cancer Symposium - Abstract No - # PD5-10 |
| 2025-12-10 | San Antonio Breast Cancer Symposium - Abstract No - # PS1-04-17 |
| 2025-12-10 | San Antonio Breast Cancer Symposium - Abstract No - # PS1-10-27 |
| 2025-12-09 | American Society of Hematology Meeting - Abstract No - #LBA-2 |
| 2025-12-08 | American Society of Hematology Meeting - Abstract No - #4981 |
| 2025-12-08 | American Society of Hematology Meeting - Abstract No - #4978 |
| 2025-12-08 | American Society of Hematology Meeting - Abstract No - #5549 |
| 2025-12-08 | American Society of Hematology Meeting - Abstract No - #906 |
| 2025-12-08 | American Society of Hematology Meeting - Abstract No - #910 |
| 2025-12-08 | American Society of Hematology Meeting - Abstract No - #844 |
| 2025-12-07 | American Society of Hematology Meeting - Abstract No - #3198 |
| 2025-12-07 | American Society of Hematology Meeting - Abstract No - #670 |
| 2025-12-07 | American Society of Hematology Meeting - Abstract No - #724 |
| 2025-12-06 | American Society of Hematology Meeting - Abstract No - #1997 |
| 2025-12-03 | Citi Global Healthcare Conference |
| 2025-12-01 | Analyst Meeting |
| 2025-11-20 | Investor Meeting - Breakout |
Past dividends on Novartis AG
| 2025-03-10 | Annual 3.5 CHF |
| 2024-03-06 | Annual 3.3 CHF |
| 2023-03-08 | Annual 3.2 CHF |
| 2022-03-07 | Annual 3.1 CHF |
| 2021-03-03 | Annual 3 CHF |
| 2020-03-02 | Annual 2.95 CHF |
| 2019-03-03 | Annual 2.85 CHF |
| 2018-03-05 | Annual 2.8 CHF |
| 2017-03-01 | Annual 2.75 CHF |
| 2016-02-24 | Annual 2.7 CHF |
| 2015-03-02 | 2.6 CHF |
| 2014-02-26 | Annual 2.45 CHF |
| 2013-02-25 | Annual 2.3 CHF |
| 2012-02-26 | Annual 2.25 CHF |
| 2011-02-23 | Annual 2.2 CHF |
| 2010-03-01 | Annual 2.1 CHF |
| 2009-02-26 | Annual 2 CHF |
| 2008-02-28 | Annual 1.6 CHF |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 50 545 51 352 -1.57% | 45 440 46 810 -2.93% | 50 317 50 407 -0.18% | 55 475 | 56 729 | 59 232 |
|
EBITDA Million USD | Released Forecast Spread | 18 613 17 036 9.25% | 17 937 18 223 -1.57% | 21 006 19 819 5.99% | 23 564 | 23 587 | 25 161 |
|
EBIT Million USD | Released Forecast Spread | 16 665 16 417 1.51% | 16 372 16 735 -2.17% | 19 494 18 983 2.69% | 21 872 | 21 790 | 23 183 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 8 371 10 562 -20.74% | 9 123 10 323 -11.63% | 13 640 13 560 0.59% | 17 230 | 17 542 | 18 709 |
|
Net income Million USD | Released Forecast Spread | 6 955 8 563 -18.78% | 14 854 10 329 43.8% | 11 939 11 438 4.38% | 14 366 | 14 270 | 15 128 |
|
EPS USD | Released Forecast Spread | 3,19 4,06 -21.46% | 7,15 5,38 32.95% | 5,92 5,53 7% | 7,24 | 7,31 | 7,89 |
| Announcement Date | 01/02/23 | 31/01/24 | 31/01/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11 829 11 498 2.88% | 12 512 12 319 1.57% | 12 823 12 666 1.24% | 13 153 12 823 2.57% | 13 233 13 050 1.4% | 14 054 14 063 -0.06% | 13 909 13 866 0.31% | 13 702 | 13 600 | 13 600 | 13 645 | 13 340 |
|
EBITDA Million USD | Released Forecast Spread | 5 294 | |||||||||||
|
EBIT Million USD | Released Forecast Spread | 4 537 4 220 7.52% | 4 953 4 667 6.12% | 5 145 4 892 5.16% | 4 859 4 435 9.56% | 5 575 5 272 5.75% | 5 925 5 827 1.68% | 5 460 5 520 -1.08% | 4 831 | 5 557 | 5 521 | 5 373 | 4 849 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3 129 3 453 -9.38% | 3 841 3 896 -1.41% | 3 385 4 028 -15.96% | 3 285 3 478 -5.55% | 4 196 4 238 -0.99% | 3 823 | ||||||
|
Net income Million USD | Released Forecast Spread | 2 688 2 459 9.31% | 3 246 2 858 13.59% | 3 189 3 197 -0.25% | 2 820 2 585 9.08% | 3 606 3 255 10.78% | 4 024 3 909 2.93% | 3 930 3 652 7.61% | 2 493 | 3 424 | 3 685 | 3 591 | 3 452 |
|
EPS USD | Released Forecast Spread | 1,31 1,19 10.18% | 1,60 1,40 14.13% | 1,58 1,48 7.03% | 1,42 1,30 9.63% | 1,83 1,65 10.96% | 2,07 1,99 3.77% | 2,04 1,87 9.02% | 1,30 | 1,79 | 1,93 | 1,88 | 1,81 |
| Announcement Date | 23/04/24 | 18/07/24 | 29/10/24 | 31/01/25 | 29/04/25 | 17/07/25 | 28/10/25 | - | - | - | - | - |
| 2026-01-05 |  | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format |
| 2026-01-11 | | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-15 | | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-20 | | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
| 2026-01-20 | | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-21 | | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-21 | | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-21 | | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-22 | | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-26 | | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Novartis AG
| 2025-12-10 | | November 2025 Sales and Revenue Release |
| 2025-12-10 | | November 2025 Sales and Revenue Release |
| 2025-12-09 | | Q2 2026 Earnings Release |
| 2025-12-09 | | November 2025 Sales and Revenue Release |
| 2025-12-09 | | November 2025 Sales and Revenue Release |
| 2025-12-05 | | November 2025 Sales and Revenue Release |
| 2025-11-30 | | Q3 2025 Earnings Release |
| 2025-11-27 | | Q2 2026 Earnings Release |
| 2025-11-19 | | Q3 2025 Earnings Release |
| 2025-11-14 | | Q2 2026 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
- Calendar Novartis AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition